Stay updated with breaking news from Annual Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
VANCOUVER, Wash. and NEW YORK, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the company will be participating in the
![[Event] 6th Annual Summit on Life Sciences IP Due Diligence - November 28th - 29th, Boston, MA | American Conference Institute (ACI) - Vimarsana News](https://jdsupra-static.s3.amazonaws.com/profile-images/hr.15935_2658.jpg)
ACI’s 6th Annual Life Sciences IP Due Diligence Summit is devoted to providing corporate and IP counsel with expert strategies for assessing, valuing, and commercializing IP assets when...
/PRNewswire/ -- Bold Therapeutics, a clinical-stage biopharmaceutical company developing novel metallotherapeutics, is announcing its selection by Life...
Hosted by C5 Group, the 21st Annual Life Sciences IP Summit returns for another exciting year with curated programming with speakers from the pharma, biotech and medical device...
VANCOUVER, British Columbia--(BUSINESS WIRE)--Jul 11, 2023--